AltrixBio
Jay L. Warner is an experienced professional with a background in business development, clinical development, commercialization, brand marketing, and market research in the healthcare industry. Currently working as Acting SVP of Business Development at AltrixBio Inc. and Chief Insight Officer at W5 Insights. Previous roles include Senior Vice President of Clinical Development and Commercialization at CeQur and various positions at Eli Lilly. Holds a Masters in Business Administration from Questrom School of Business, Boston University.
This person is not in any teams
AltrixBio
AltrixBio is an early-stage company focused on advancing our lead platform: LuCI™ AJN 003, an oral drug that replicates the metabolic success of bariatric surgery in treated of Type 2 Diabetes.